p53 gain-of-function: tumor biology and bioinformatics come together

Eugene V Koonin1, Igor B Rogozin, Galina V Glazko

  • 1National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland 20894, USA. koonin@ncbi.nlm.nih.gov

Insights

The p53 tumor suppressor gene can gain new functions through mutations, driving tumor evolution. These gain-of-function mutations, particularly in key DNA-binding areas, show distinct patterns across different cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The p53 gene is traditionally recognized for its tumor suppressor roles.
  • However, missense mutations can lead to gain-of-function (GOF) activities, altering p53's biological functions.
  • These GOF mutations can confer novel transcriptional transactivation and protein-protein interaction capabilities.

Purpose of the Study:

  • To investigate the prevalence and evolutionary patterns of p53 gain-of-function mutations in tumors.
  • To analyze the functional and evolutionary implications of p53 mutation hotspots.
  • To explore the tumor-specific nature of p53 evolution.

Main Methods:

  • Bioinformatic analysis of somatic mutation spectra in the p53 gene.
  • Identification and analysis of mutation hotspots.
  • Comparison of mutation patterns across different tumor types and germline mutations (Li-Fraumeni syndrome).

Main Results:

  • Mutation hotspots in the p53 gene exhibit evidence of positive selection, suggesting GOF.
  • Hotspots are concentrated in functionally critical and evolutionarily conserved DNA-binding domains.
  • Distinct mutation spectra were observed across different tumor types and the germline, indicating tumor-specific evolutionary pathways.

Conclusions:

  • Gain-of-function mutations represent a prevalent mode of p53 evolution in cancer.
  • The location of hotspots in conserved functional domains highlights the importance of these regions for novel functions.
  • Tumor-specific p53 evolution suggests complex adaptive processes and the acquisition of distinct oncogenic functions in different cancers.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...